A higher pretreatment circulating monocyte count can be considered as a useful prognostic marker in patients with oral cavity cancer.
No takes yet. Share an insight, caveat, or question.
Tsai et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: